Overview

Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of using gene therapy via intramuscular injections of the calf for patients with chronic non-healing foot ulcers.
Phase:
Phase 3
Details
Lead Sponsor:
Helixmith Co., Ltd.